IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 85 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $22,000 | -76.8% | 11,899 | -63.7% | 0.00% | -80.0% |
| Q3 2019 | $95,000 | -56.8% | 32,804 | -60.2% | 0.01% | -58.3% |
| Q2 2019 | $220,000 | +105.6% | 82,504 | +96.0% | 0.01% | +100.0% |
| Q1 2019 | $107,000 | +94.5% | 42,088 | +110.5% | 0.01% | +50.0% |
| Q4 2018 | $55,000 | -83.3% | 19,997 | -45.8% | 0.00% | -73.3% |
| Q3 2018 | $329,000 | – | 36,928 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
| Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
| Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
| Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
| DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
| 683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
| Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
| Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
| TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |